Recent Publications on Iduronate Sulfatase: |  |
Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II.
Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is a rare X-linked...
Direct Link | 24th September, 2008
| Royal Manchester Children's Hospital, Manchester, UK.
|
| Idursulfase: a poor risk-benefit balance in type II mucopolysaccharidosis.
| 15th August, 2008
|
|
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.
Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is a rare X-linked...
Direct Link | 8th August, 2008
| Willink Biochemical Genetics Unit, Royal Manchester Children's Hospital,
|
Early response to idursulfase treatment in a 3 year-old boy affected of Hunter syndrome.
We present a 3-year-old boy affected with Hunter syndrome. When we first...
Direct Link | 5th August, 2008
|
|
Molecular investigations of a novel iduronate-2-sulfatase mutant in a Chinese patient.
BACKGROUND: Molecular investigations of iduronate-2-sulfatase (IDS)...
Direct Link | 1st August, 2008
| Department of Chemical Pathology, The Chinese University of Hong Kong,
|
Idursulfase for the treatment of mucopolysaccharidosis II.
Human recombinant proteins are being used to treat an increasing number of...
Direct Link | 9th April, 2008
| University of British Columbia and the Child and Family Research
|
| [Clinical study of enzyme replacement therapy with idursulfase]
| 3rd April, 2008
| Hospital Infantil Universitario Nino Jesus, 28009 Madrid, Espana.
|
Idursulfase in Hunter syndrome treatment.
Hunter syndrome (mucopolysaccharidosis II, MPS II) is a rare X-linked...
Direct Link | 7th March, 2008
| Department of Environmental Medicine, University of Rochester, School of
|
Enzyme reconstitution/replacement therapy for lysosomal storage diseases.
PURPOSE OF REVIEW: Over the past 15 years, the lysosomal storage diseases...
Direct Link | 26th February, 2008
| Division of Human Genetics, Cincinnati Children's Hospital Medical Center
|
[Computational prediction of the tertiary structure of the human iduronate 2-sulfate sulfatase]
INTRODUCTION: Hunter syndrome (MC KUSIK 309900) or mucopolysacharidosis...
Direct Link | 30th October, 2007
| Instituto de Errores Innatos del Metabolismo, Facultad de Ciencias,
|
Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins.
Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder...
Direct Link | 27th September, 2007
| Department of Pediatrics, Saint Louis University, Pediatric Research
|
Preclinical dose ranging studies for enzyme replacement therapy with idursulfase in a knock-out mouse model of MPS II.
Mucopolysaccharidosis II (MPS II; Hunter syndrome) is an X-linked...
Direct Link | 28th July, 2007
| Shire Human Genetic Therapies, Inc., Preclinical Research, 700 Main
|
| [Overview of enzyme replacement therapy in mucopolysaccharidosis]
| 29th June, 2007
| Centre de Reference des Maladies Hereditaires du Metabolisme, Hopital
|
| Treatment for Hunter syndrome approved.
| 21st March, 2007
|
|
| First treatment for Hunter syndrome.
| 17th March, 2007
|
|
